Literature DB >> 9862556

Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines.

H C Schulberg1, W Katon, G E Simon, A J Rush.   

Abstract

The Depression Guideline Panel of the Agency for Health Care Policy and Research in 1993 published recommendations for treating major depression in primary care practice that were often based on studies of tertiary care psychiatric patients. We reviewed reports of randomized controlled trials in primary care settings published between 1992 and 1998. This evidence indicates that both antidepressant pharmacotherapy and time-limited depression-targeted psychotherapies are efficacious when transferred from psychiatric to primary care settings. In most cases, the choice between these treatments should depend on patient preference. Studies to date suggest that improving treatment of depression in primary care requires properly organized treatment programs, regular patient follow-up, monitoring of treatment adherence, and a prominent role for the mental health specialist as educator, consultant, and clinician for the more severely ill. Future research should focus on how guidelines are best implemented in routine practice, since conventional dissemination strategies have little impact.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862556     DOI: 10.1001/archpsyc.55.12.1121

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  73 in total

1.  Quality of web based information on treatment of depression: cross sectional survey.

Authors:  K M Griffiths; H Christensen
Journal:  BMJ       Date:  2000-12-16

Review 2.  Practice guidelines and measurement: state-of-the-science.

Authors:  Patricia C Dykes
Journal:  Nurs Outlook       Date:  2003 Mar-Apr       Impact factor: 3.250

3.  The nature of clinical depression: symptoms, syndromes, and behavior analysis.

Authors:  Jonathan W Kanter; Andrew M Busch; Cristal E Weeks; Sara J Landes
Journal:  Behav Anal       Date:  2008

4.  Depression and suicidal behaviors in Medicare primary care patients under age 65.

Authors:  Bruce Friedman; Yeates Conwell; Rachel Ritz Delavan; Brenda R Wamsley; Gerald M Eggert
Journal:  J Gen Intern Med       Date:  2005-05       Impact factor: 5.128

5.  Comorbid chronic illness and the diagnosis and treatment of depression in safety net primary care settings.

Authors:  Chizobam Ani; Mohsen Bazargan; David Hindman; Douglas Bell; Michael Rodriguez; Richard S Baker
Journal:  J Am Board Fam Med       Date:  2009 Mar-Apr       Impact factor: 2.657

6.  Initial rate of improvement in relation to remission of major depressive disorder in primary care.

Authors:  Anton C Vergouwen; Huibert Burger; Frank Koerselman; Theo J Verheij
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

7.  A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.

Authors:  Charles H Bombardier; Jesse R Fann; Catherine S Wilson; Allen W Heinemann; J Scott Richards; Ann Marie Warren; Larry Brooks; Catherine A Warms; Nancy R Temkin; Denise G Tate
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

Review 8.  Emerging models of depression care: multi-level ('6 P') strategies.

Authors:  Harold Alan Pincus; Lin Hough; Jeanie Knox Houtsinger; Bruce L Rollman; Richard G Frank
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

9.  Effectiveness of collaborative care depression treatment in Veterans' Affairs primary care.

Authors:  Susan C Hedrick; Edmund F Chaney; Bradford Felker; Chuan-Fen Liu; Nicole Hasenberg; Patrick Heagerty; Jan Buchanan; Rocco Bagala; Diane Greenberg; Grady Paden; Stephan D Fihn; Wayne Katon
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

10.  Towards personalizing treatment for depression : developing treatment values markers.

Authors:  Marsha N Wittink; Knashawn H Morales; Mark Cary; Joseph J Gallo; Stephen J Bartels
Journal:  Patient       Date:  2013       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.